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INTRODUCTION
Injection augmentation mammoplasty with hydrophilic
polyacrylamide gel (PAAG) has become very popular in
China since 1997. It has been claimed by users to be a safe
method with good cosmetic results. Aspiration is claimed to be
an effective and convenient way for removal of the injected gel.
We report the mammography, ultrasonography and magnetic
resonance imaging (MRI) of two patients undergoing PAAG




A 25-year-old female underwent PAAG mammoplasty 13 months
before presenting with mastalgia and breast lumps.
Mammography showed a non-specific generalized increase in density
of the whole breasts. No definite discrete mass was identified (Fig. 1a).
Ultrasonography showed anechoic substance in the infraglandular
location. It was relatively homogenous with echogenic foci within the
substance. There was sharp delineation between glandular tissue and the
injected gel. At the site of breast lumps and tenderness, there was a
honeycomb-like anechoic region with an ill-defined border with the
glandular tissue. Pockets of gel were noted within the glandular tissue.
Migration of the injected gel to the infraclavicular region was also
identified (Fig. 1b).
MRI showed homogenous hyperintensity of the gel on T2-weighted
images. It was hypointense on T1-weighted images. It was predominantly
positioned infraglandularly. Corresponding to the site of tenderness and
ultrasonographic honeycomb location, there was marked enhancement after
administration of contrast medium and the border between the gel and the
glandular tissue was ill defined (Fig. 1c–e).
Ultrasound-guided aspiration with a 16 G hypodermic needle of the
honeycomb site yielded 2 ml yellowish gel-like substance. Tru cut biopsy
under local anaesthesia was performed and fibrotic tissue was obtained.
Case 2
A 46-year-old lady presented with generalized breast discomfort 4
months after PAAG injections. No specific site of tenderness could be
identified. Mammography showed a generalized increase in the density of
the breast tissue with lobulate outline. Ultrasound showed a well-defined
anechoic substance in the infraglandular layer. No honeycomb appearance
was identified (Fig. 2a). MRI of the breast showed no abnormal
enhancement (Fig. 2b).
DISCUSSION
Hydrophilic PAAG has been adopted for the plastic repair of
soft tissue such as the lip. It is claimed to be non-toxic and to
cause little fibrous capsule formation, and its application is
predominantly reported in the Russian literature [1–3]. Its use
in the anterior chamber of the eye has, however, been
withdrawn because of the association of delayed sustained
increase in intraocular pressure [4]. One animal study showed
there was a local histological reaction and thin fibrous
membrane formation around PAAG, which gradually became
stiff. The shape and location of the injected PAAG was not
stable and could not be drawn out completely [5].
There is little literature about the applications and
complications of PAAG in breast augmentation, as it is not
widely practised in Western countries. It was only introduced in
China for breast augmentation in 1997, and so the long-term
complications of the procedure cannot be fully evaluated.
Cheng’s study reported 12 patients with complications after
PAAG augmentation. Breast induration or lumps were found to
be the most common complications [6]. Haematoma, inflam-
mation, infection, mastalgia and laceration have also been
reported. PAAG fillers can partially degrade and carcinogenic
and mutagenic monomers can be released [7]. The long-term
side effects have not been documented.
In the management of these patients, the clinical features
and symptoms are obviously important. Radiological evalu-
ation also has a role as revealed in our cases. The mammo-
graphic appearance is very non-specific, however,
1477-6804/03/$30.00/0 q 2003 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
Guarantor and correspondent: Wynnie Wai Man Lam, MD, Department
of Diagnostic Radiology and Organ Imaging, Faculty of Medicine, The
Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New
Territories, Hong Kong. Tel: þ852-2632-2291; Fax: þ852-2636-0012;
E-mail: wynnie@cuhk.edu.hk
Clinical Radiology Extra (2003) 58: 61–63
doi:10.1016/S1477-6804(03)00014-1, available online at www.sciencedirect.com
ultrasonography is a very useful technique. It identifies the
exact location of the injected PAAG and demonstrates the layer
of tissue involved. From the sonographic appearance of our
reported cases and correlation with clinical symptoms, it is
suggested that ultrasound can be used to delineate the site of the
complications. The honeycomb appearance might be related to
a fibrotic reaction and local inflammation, causing mastalgia
and lumps. Our clinical findings agree with the findings of the
animal study [5]. In the absence of complications, the injected
PAAG appears as a homogenous hypoechoic layer, as indicated
by patient 2. MRI also shows the position of the injected gel.
Contrast medium enhancement allows delineation of the
complicated site. However, one cannot differentiate carcinoma
from fibrotic reaction, and the ultimate diagnosis relies on
histology. The accessibility of MRI will also limit its routine
usage in the assessment of the patients.
Aspiration of the gel with a 16 G hypodermic needle has
proved to be possible. Cheng reported the use of cannula
suction procedure via a 3 mm-diameter cannula to remove
PAAG [6]. Saline irrigation and massage is required to
Fig. 1 – A 25-year-old woman with PAAG mammoplasty 13 months ago presenting with mastalgia and breast lumps. (a) Mediolateral oblique mammograms
showing homogeneously dense breasts with no discernible boundary between the breast tissue and the injected PAAG. (b) Transverse sonogram at the right
breast tail region shows honeycomb like anechoic region (black arrow) with ill-defined border with the glandular tissue. This corresponds to the area of
enhancement (d). Underlying pectoralis muscle is indicated by white arrow. (c) T1-weighted (FOV: 32 cm, TR/TE: 425/12, NEX: 2) axial image of both
breasts. Hypointense PAAG (arrows) predominantly infraglandular in location. (d) T2-weighted, fat-suppressed spectral presaturation inversion recovery
(SPIR) (FOV: 32 cm, TR/TE: 4000/120, turbo factor of 24, NEX: 3) axial images. Hyperintense PAAG with small pocket of gel (white arrows) extending into
the glandular tissue. (e) Subtracted T1 SPIR image (FOV: 32 cm, TR/TE: 450/12, NEX: 2). There is enhancement of the glandular tissue at the right breast tail
(arrow), which corresponds to the site of maximal tenderness.
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soften the implanted gel. Ultrasound might then serve as a
useful guide to monitor whether PAAG has been completely
removed [6]. Open suction procedure, mammotomy and
partial mastectomy may be required to treat different
complications.
There is increasing use of injection mammoplasty with
PAAG and it is important to be familiar with the radiological
appearance of complicated and non-complicated cases. Ultra-
sonography has shown to be useful in demonstrating the extent
of involvement of complications.
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Fig. 2 – A 46-year-old lady with PAAG injection 4 months previously
presented with generalized breast discomfort without specific site of
tenderness. (a) Transverse sonogram shows a well-defined anechoic
substance (white arrows) in the infraglandular layer. No honeycomb
appearance evident. Underlying pectoralis muscle is indicated by black
arrows. (b) T2-weighted (FOV: 32 cm, TR/TE: 2000/100, turbo factor of
18, NEX: 3) sagittal image of the breast shows the hyperintense gel
(arrows) is infraglandular in location with clear demarcation from the
overlying breast parenchyma.
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